The association of small accessory marker chromosomes in man with specific abnormalities has been difficult to define owing to variations in the chromosome origin and the size of the markers. In a patient with typical Turner phenotype and a 45,X/46,X, +mar karyotype the marker was shown to be a small portion ofthe long arm of the X chromosome which included the centromere and XIST, a candidate gene for the X inactivation centre. Therefore the lack of any additional abnormalities was attributed to inactivation of the portion of the X chromosome in the marker. In a patient with a 47,XY, +mar karyotype the mar was a small ring X chromosome which did not contain the XIST gene. For both markers the short arm breakpoints were localised between UBEl and DXS423E. The congenital abnormalities of the male patient were attributed to the lack ofX inactivation ofthe small ring and therefore disomic expression of normal genes possessed by the marker. (JMed Genet 1995;32:113-116) The chromosomal origins of small accessory marker chromosomes may be identified by fluorescence in situ hybridisation (FISH) using chromosome specific pericentric repeat probes. Markers 5 Markers which are derived from the X chromosome and contain the X inactivation centre would be expected to be late replicating (inactive), and therefore be of little clinical significance. In contrast, markers lacking the X inactivation centre would not be inactivated and can therefore contain active genes. For such markers, it would be expected that the extra copies of the normal genes, resulting in two active copies rather than a single active copy, will be sufficient to result in an abnormal phenotype.
Abstract
The association of small accessory marker chromosomes in man with specific abnormalities has been difficult to define owing to variations in the chromosome origin and the size of the markers. In a patient with typical Turner phenotype and a 45,X/46,X, +mar karyotype the marker was shown to be a small portion ofthe long arm of the X chromosome which included the centromere and XIST, a candidate gene for the X inactivation centre. Therefore the lack of any additional abnormalities was attributed to inactivation of the portion of the X chromosome in the marker. In a patient with a 47,XY, +mar karyotype the mar was a small ring X chromosome which did not contain the XIST gene. For both markers the short arm breakpoints were localised between UBEl and DXS423E. The congenital abnormalities of the male patient were attributed to the lack ofX inactivation ofthe small ring and therefore disomic ex X inactivation may be determined cytogenetically by study of replication timing during the cell cycle. Using this approach it is difficult to assess the status of very small segments of chromosome, such as a marker. XIST is considered to be candidate gene for X inactivation since it is only expressed on the inactive X chromosome and maps to the region of the X inactivation centre.'2-14 In this report two patients with small ring chromosomes were studied. These rings were identified as X derived and the presence ofthe inactivation centre was determined by FISH using a probe specific for the XIST gene. (figs 1D, 2D) . This was consistent with the larger size of the marker in the second patient. These results are summarised in the table.
Materials and methods

Discussion
The small ring chromosomes in both patients were derived from the X chromosome and were positive for DXS1 adjacent to the centromere on the long arm. The short arm breakpoints of both rings were between UBE1 and DXS423E. These studies aim to give information which can provide prospective clinical outcomes for patients with similar marker chromosomes. This can only be achieved with both the evaluation of the clinical phenotype of the patient and the delineation of the euchromatin present in the ring. Accumulation of similar cases should allow particular phenotypic characteristics to be assigned to disomy for a defined region of the X chromosome, as has been described for chromosome 21 and Down's syndrome."9
The XIST gene is a candidate for a gene which determines X inactivation since it is only expressed from the inactive X, and maps to the region known to contain the X inactivation region.12-14 Ring chromosomes containing XIST are likely to be inactivated and the presence of the ring is therefore unlikely to contribute to the patient's phenotype. When XIST is absent, the euchromatin of the marker will be active resulting in disomic expression of normal genes. The subsequent overexpression and interactions of these genes is the genetic basis for the abnormal phenotype.
It is now established that patients with a small ring marker derived from the X chromosome in association with a 45,X karyotype show the typical Turner phenotype if the X inactivation centre is present (patient 2 of this report, patients presented in references 17 and 20) . It is unlikely that the lack of phenotypic effect of the r(X) in such patients can be explained by the presence of mosaicism for the marker. A smaller r(X) lacking the XIST gene has been reported in 70% of cells in a patient with a 45, X/46,X, + r(X) karyotype. " In addition to the expected Turner phenotype, this patient had learning difficulties. Therefore, in patient 2 of this report, the lack of additional phenotypic abnormalities is likely to be attributed to X inactivation ofthe r(X) rather than the presence of mosaicism. Among the X derived markers lacking the XIST gene, in addition to Turner's syndrome, there is mental retardation and multiple congenital malformations. 17 21 " It has been suggested that within this group the degree of clinical severity of such patients correlates with the size or the frequency, or both, of the mar(X)s. 17 The male patient (patient 1) had global developmental delay and minor malformations. This phenotype may be attributed to the abnormal dosage (two rather than the single dose) of a gene or genes located in the euchromatin of the ring chromosome, since XIST was not present on this chromosome and therefore the r(X) was not inactivated. A male patient with a similar karyotype, 47,XY,+r(X), has been reported, although the location of the euchromatin on the X chromosome was not determined.3 This patient had global developmental delay and malformations, inguinal hernias, cryptorchidism, adducted, low inserted thumbs, dysplastic ears, and a haemangioma of the upper eyelid and nasal alae.
A further male patient with 47,XY,+r(X) has been described and in this case XIST was not present or expressed. 23 The phenotype of this patient was of mild learning difficulties, joint laxity, long, thin fingers, but no other malformations. All three of these male patients were variably retarded in motor and mental development but there were no obvious similarities in congenital abnormalities. These differences are presumably because of variation in the euchromatin present in each marker chromosome. Comparisons between clinical phenotypes of these markers will require additional patients and detailed molecular characterisation of the X chromosome content of each marker.
